Skip to main content
IRWD logo

IRWD · Ironwood Pharmaceuticals Inc · Executive Compensation

Track IRWD — free
$4.67 -0.12 (-2.41%) Play latest call Q3 2026 earnings call transcript
Market Cap
$767.33M
Shares
165.55M
Volume · Nov 19 948.72K Avg daily vol (3M) 2.1M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Thomas McCourt Retired 2026-10-16
Tammi Gaskins Appointed 2026-10-16
Tammi Gaskins Appointed 2026-10-16
Ronald Silver Appointed 2026-05-13
Gregory Martini
“Mr. Martini’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
Resigned 2026-05-13
Andrew Dreyfus
“Mr. Dreyfus’ decision to resign is due to his appointment as President and Chief Executive Officer of the National Institute for Health Care Management (NIHCM) Foundation and was not a result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.”
Resigned 2025-10-10
Gregory Martini Appointed 2025-01-29
Thomas McCourt Appointed 2024-12-05
Sravan K. Emany
“Mr. Emany’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
Resigned 2024-12-05
Sravan K. Emany
“Mr. Emany’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
Resigned 2024-12-05
Andrew Davis Resigned 2024-11-12
Sravan K. Emany Appointed 2024-06-20
Catherine Moukheibir Appointed 2023-06-22
Jay Shepard Appointed 2023-06-22
Julie McHugh Appointed 2023-06-22
Marla Kessler Appointed 2023-06-22
Thomas McCourt Already on the board
Since at least 2021: re-election or new board role
2023-06-22
Jon Duane Appointed 2023-06-22
Andrew Dreyfus Appointed 2023-06-22
Alexander Denner Appointed 2023-06-22
Mark Currie Appointed 2023-06-22
Jason Rickard
“Mr. Rickard’s role elimination is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Terminated 2023-04-11
Sravan K. Emany Appointed 2021-12-01

Leadership

Key facts CIK 1446847 CUSIP 46333X108 13F (30d) 243 filings 221 filers Visit website Investor relations